HOME Top Market Reports Proteomics Market by Instrument, Reagent & Service (Spectroscopy, Chromatography, Electrophoresis, Immunoassay, HPLC, X-Ray Crystallography, Mass Spectrometry and Surface Plasmon Resonance), Application (Diagnostics, Drug Discovery) - Forecast to 2021

Proteomics Market by Instrument, Reagent & Service (Spectroscopy, Chromatography, Electrophoresis, Immunoassay, HPLC, X-Ray Crystallography, Mass Spectrometry and Surface Plasmon Resonance), Application (Diagnostics, Drug Discovery) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: BT 2341

Discount on Reports  

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global proteomics market is estimated to grow at a CAGR of 11.7% from 2016 to 2021 to reach USD 21.87 Billion by 2021. The growth of the market can be attributed to factors such as the increasing need of proteomics in diagnosis and drug discovery, and various advancements in technologies used in proteomics, rising R&D expenditure and the increasing need for personalized medicine. However, he reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers is expected to restrain the market growth to a certain extent.

In this report, the market is segmented on the basis of instrumentation technology, application, reagent, and services & software available in the proteomics market. This report also provides market information on major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The report provides an insight on the proteomics product matrix which presents a comparative analysis of product portfolios of leading market players. Moreover, the vendor benchmarking provided in the report illustrates the comparison between the geographic and product strength of top companies.

The global market for proteomics is dominated by market players such as Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.). The leading players are continuously developing new and innovative products to maintain their shares in the proteomics market.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global proteomics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Proteomics Market

To know about the assumptions considered for the study, download the pdf brochure

Target Audience

  • Proteomics Instrumentation Technology Product Manufacturers
  • Researchers and Scientists
  • Proteomics Industry Consulting Firms
  • Proteomics Research and Development (R&D) Companies
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms

Scope of the Report

Global Proteomics Market

This research report categorizes the global market proteomics into the following segments:

Global Proteomics Market, by Instrumentation Technology

  • Protein Microarrays
    • Biochips
      • Protein Chips
      • Lab-on-chips
    • Microarray Instruments
      • Integrated Systems
      • Arrayers
      • Microarray Scanners
  • Spectroscopy
    • Mass Spectrometry
    • NMR Spectroscopy
    • Circular Dichroism (CD) Spectroscopy
  • X-ray Crystallography
  • Chromatography
    • HPLC Systems
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Surface Plasmon Resonance (SPR) Systems
  • Protein Fractionation Systems

Global Proteomics Market, by Reagents

  • Microarray Reagents
  • Spectroscopy Reagents
  • X-ray Crystallography Reagents
  • Chromatography Reagents
  • Electrophoresis Reagents
  • Immunoassay Reagents
  • Protein Fractionation Reagents

Global Proteomics Market, by Services and Software

  • Analytical Laboratory Services
    • Protein Identification
    • Protein Separation
    • Protein Sequencing
  • Data Analysis & Maintenance
    • Bioinformatics Databases
    • Bioinformatics Tools
  • Quantitation Services

Global Proteomics Market, by Application

  • Drug Discovery
  • Clinical Diagnosis
  • Other Applications

Global Proteomics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East and Africa

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific Proteomics market in South Korea, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Personalized medicine –a driving force for continuous research & development in proteomics market

Personalized medicine has the potential to provide effective and safer treatments and can help in improving patient outcomes by early detection of diseases and thereby leading to better treatment. Proteomics findings have proven to be extremely useful to build diagnostic tests that help screen patients and prescribe drugs. Proteomics technologies help unravel the biochemical and physiological mechanisms of complex multivariate diseases at the functional molecular level. Proteomics biomarkers help in understanding the range of malignancies which are used in screening, diagnosis, and prognosis and identifying the underlying processes involved in the disease.

Personalized medicines offer many benefits over traditional medicines such as disease surveillance and provides safer drug therapies. Personalized medicines can be used to treat melanoma cancer, thyroid cancer, colorectal cancer lung and pancreatic cancer, and breast cancer. Increasing awareness about personal medicine in developed countries such as the US and European countries has resulted in increasing acceptance of personalized medicines. The rising awareness and growing requirement of personalized medicine across the world is expected to increase the uptake of proteomic technologies as diagnostic tools for improving the overall outcome and quality of care.

technological innovation - opening new avenues for growth in proteomics market

Several players are focusing on continuous product launches and enhancements to enter new markets or strengthen their presence across the globe. Technological advancements such as high throughput, enhanced sensitivity, and high resolution in proteomics are generating interest in research laboratories as well as in pharmaceutical and biotechnology companies. One of the major developments in this field is that of protein biochips which give higher throughput and speed by allowing an assortment of multiple tests to be performed simultaneously on a single substrate. Similarly, another major development is the increased resolution of mass spectrometry, which helps extract more information from a minimal amount of sample.

The emergence of dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF-TOF help gather detailed data about protein composition. Improved forms of liquid chromatography and gel electrophoresis have become significant tools in protein identification and separation methods. Two-dimensional gel electrophoresis, which is based on isoelectric focusing and denaturing polyacrylamide gel matrix for protein separation, have also been developed. Such technological advancements and developments are propelling the growth of the proteomics market.

Proteomics Market

Proteomics Market

Asia pacific countries showcase high growth potential for proteomics market

Countries in the APAC region, such as China and India have shown remarkable economic growth in the past decade, and are likely to grow at higher CAGR in the coming years. China and India are serving as growth engines for proteomics tools and reagent and service vendors. Growth in these markets is primarily driven by pharmaceutical drug development and diagnostic product development in this region. With many of the developed economies reaching saturation, the Asian market will serve as the key market for manufacturers and suppliers.

Currently, most Asian countries lack established business models but possess scientific talent to develop strong domestic biotechnology industries. Hence, the number of collaborations, mergers, and acquisitions are on a rise in the Asian continent, which is expected to drive the market for proteomics reagents in this market. Several Asian economies have modified regulations and monitored the implementation of procedures, policies, and guidelines to promote innovation and commercialization; this is attracting many homegrown entrepreneurs as well as global leaders to establish a foothold in the region. As the number of biotechnology and pharmaceutical companies in this region increases, it will propel the market for proteomics.

Market Dynamics

Drivers

  • Proteomics bridges the gap between genome sequence and cellular behaviour
  • Increasing pharmaceutical and biotech R&D expenditure
  • Availability of government & private funding

Restraints

  • Disconnect between biomarker discovery and biomarker approval by regulatory authorities
  • Expensive tools & instruments and their maintenance

Opportunities

  • Growing applications of nanotechnology
  • Biomarker identification
  • Untapped emerging markets

Challenges

  • Managing large volumes of data generated in proteomics research
  • Dearth of skilled researchers and mandatory training cost
  • Key Market Trend

Shift from Genomics to Proteomics

Over the last few years, the focus of researchers has shifted from genomics to proteomics, which can be attributed to the change in focus from genes to proteins. While genomics studies help in understanding the molecular basis of certain diseases, proteomics delineates the functional units of a cell, protein, and their intricate interaction networks and signaling pathways for the underlying disease. In the post-genomic era, proteomic technologies are likely to play a vital role in the field of diagnostics and drug discovery. In addition, the shift has enhanced the process of sample preparation; increasing industrialization is further propelling the expansion of sample preparation technologies.

The applications of proteomics have extended to various areas of science, from deciphering of molecular pathogenesis of diseases, characterization of novel drug targets, to the discovery of potential diagnostic and prognostic biomarkers. Proteomics has simplified the identification and quantification of proteins associated with a particular disease by encoding the modified levels of protein expression and/or PTMs between the control and disease states under investigation. Such comparative and quantitative correlations made between cellular, tissue, and biofluid protein levels allow therapeutic monitoring of a disease state.

Key Questions

  • Currently, which are most preferred instrumentation technologies in proteomics and which will be the disruptive technologies in the near future?
  • How proteomics would change the future of drug discovery and clinical diagnostics?
  • Most of the vendors have opted agreements, collaborations, & partnerships as the key growth strategies. Where will it take the industry in the mid to long term in terms of innovation and market growth?
  • What are the growth strategies and strengths of market players impacting their market positioning?

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Proteomics Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Proteomics Market: Research Methodology (Page No. - 23)
    2.1 Research Approach
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Size Estimation
    2.3 Breakdown and Data Triangulation
    2.4 Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 36)
    4.1 Global Proteomics Market Overview
    4.2 Asia-Pacific: Market Share, By Application (2015)
    4.3 Geographic Snapshot
    4.4 Geographic Mix
    4.5 Market for Proteomics: Developed vs Developing Countries

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Key Proteomics Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Increasing Demand for Personalized Medicine
                    5.2.1.2 Proteomics Bridges the Gap Between Genome Sequence and Cellular Behavior
                    5.2.1.3 Increasing Pharmaceutical and Biotech R&D Expenditure
                    5.2.1.4 Technological Advancements
                    5.2.1.5 Availability of Government and Private Funding
           5.2.2 Key Market Restraints
                    5.2.2.1 Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research
                    5.2.2.2 Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
                    5.2.2.3 Expensive Tools and Instruments and Their Maintenance
           5.2.3 Key Market Opportunities
                    5.2.3.1 Growing Applications of Nanotechnology
                    5.2.3.2 Biomarker Identification
                    5.2.3.3 Untapped Emerging Markets
           5.2.4 Key Market Challenges
                    5.2.4.1 Managing Large Volumes of Data Generated in Proteomics Research
                    5.2.4.2 Dearth of Skilled Researchers and Mandatory Training Cost

6 Industry Insights (Page No. - 49)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Shift From Genomics to Proteomics
           6.2.2 Growing Number of Collaborations in Proteomics Market
    6.3 Product Portfolio Analysis
    6.4 Regulatory Analysis
           6.4.1 North America

7 Global Proteomics Market, By Instrumentation Technology (Page No. - 54)
    7.1 Introduction
    7.2 Protein Microarrays
           7.2.1 Biochips
                    7.2.1.1 Protein Chips
                    7.2.1.2 Lab-On-Chips (Microfluidics)
           7.2.2 Microarray Instruments
                    7.2.2.1 Integrated Systems
                    7.2.2.2 Arrayers
                    7.2.2.3 Microarray Scanners
    7.3 Spectroscopy
           7.3.1 Mass Spectrometry
           7.3.2 NMR Spectroscopy
           7.3.3 CD Spectroscopy
    7.4 X-Ray Crystallography
    7.5 Chromatography
           7.5.1 HPLC
           7.5.2 Ion Chromatography
           7.5.3 Affinity Chromatography
           7.5.4 Supercritical Fluid Chromatography
    7.6 Electrophoresis
           7.6.1 Gel Electrophoresis
           7.6.2 Capillary Electrophoresis
    7.7 Surface Plasmon Resonance (SPR)
    7.8 Protein Fractionation

8 Global Proteomics Market, By Reagent (Page No. - 86)
    8.1 Introduction
    8.2 Protein Microarray Reagents
    8.3 Spectroscopy Reagents
    8.4 X-Ray Crystallography Reagents
    8.5 Chromatography Reagents
    8.6 Electrophoresis Reagents
    8.7 Immunoassay Reagents
    8.8 Protein Fractionation Reagents

9 Global Proteomics Market, By Services and Software (Page No. - 96)
    9.1 Introduction
    9.2 Analytical Laboratory Services
           9.2.1 Protein Identification
           9.2.2 Protein Separation
           9.2.3 Protein Sequencing
    9.3 Data Analysis & Maintenance
           9.3.1 Bioinformatics Databases
           9.3.2 Bioinformatics Tools
    9.4 Quantitation Services

10 Global Proteomics Market, By Application (Page No. - 109)
     10.1 Introduction
     10.2 Drug Discovery
     10.3 Clinical Diagnostics
     10.4 Other Proteomics Applications

11 Global Proteomics Market, By Region (Page No. - 116)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 Italy
             11.3.4 U.K.
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific
             11.4.1 China
             11.4.2 India
             11.4.3 Japan
             11.4.4 Rest of Asia-Pacific
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 173)
     12.1 Overview
     12.2 Strategic Benchmarking
             12.2.1 Increasing Focus on Product Launches and Enhancements
     12.3 Market Ranking Analysis
             12.3.1 Proteomic Instrumentation Technology
             12.3.2 Proteomic Reagents
             12.3.3 Proteomics Services and Software
     12.4 Competitive Situations and Trends
             12.4.1 Product Launches and Enhancements
             12.4.2 Partnerships, Agreements, Collaborations, and Alliances
             12.4.3 Acquisitions
             12.4.4 Expansions

13 Company Profiles (Page No. - 185)
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Introduction
     13.2 Thermo Fisher Scientific, Inc.
     13.3 Agilent Technologies, Inc.
     13.4 Bio-Rad Laboratories, Inc.
     13.5 Merck KGaA
     13.6 Danaher Corporation
     13.7 Luminex Corporation
     13.8 Perkinelmer, Inc.
     13.9 Waters Corporation
     13.10 GE Healthcare
     13.11 Bruker Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 239)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (151 Tables)

Table 1 Product Portfolio Analysis: Proteomics Market
Table 2 U.S. FDA: Classification of Proteomics Instruments
Table 3 Global Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 4 Global Proteomics Instrumentation Technology Market Size, By Country, 2014–2021 (USD Million)
Table 5 Global Protein Microarrays Market Size, By Product, 2014–2021 (USD Million)
Table 6 Global Protein Microarrays Market Size, By Country, 2014–2021 (USD Million)
Table 7 Global Biochips Market Size, By Type, 2014–2021 (USD Million)
Table 8 Global Biochips Market Size, By Country, 2014–2021 (USD Million)
Table 9 Global Protein Chips Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Lab-On-Chips Market Size, By Country,2016–2021 (USD Million)
Table 11 Global Microarray Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 12 Global Microarray Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 13 Global Integrated Systems Market Size, By Country, 2014-2021 (USD Million)
Table 14 Global Arrayers Market Size, By Country, 2014-2021 (USD Million)
Table 15 Global Microarray Scanners Market Size, By Country, 2014-2021 (USD Million)
Table 16 Global Spectroscopy Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 17 Global Spectroscopy Instruments Market Size, By Country, 2014-2021 (USD Million)
Table 18 Global Mass Spectrometry Market Size, By Country, 2014-2021 (USD Million)
Table 19 Global NMR Spectroscopy Market Size, By Country, 2014–2021 (USD Million)
Table 20 Global CD Spectroscopy Market Size, By Country, 2014–2021 (USD Million)
Table 21 Global X-Ray Crystallography Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Chromatography Market Size, By Type, 2014–2021 (USD Million)
Table 23 Global Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 24 Global HPLC Systems Market Size, By Country, 2014–2021 (USD Million)
Table 25 Global Ion Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 26 Global Affinity Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 27 Global Supercritical Fluid Chromatography Market Size, By Country, 2014–2021 (USD Million)
Table 28 Global Electrophoresis Market Size, By Type, 2014–2021 (USD Million)
Table 29 Global Electrophoresis Market Size, By Country, 2014–2021 (USD Million)
Table 30 Global Gel Electrophoresis Market Size, By Country, 2014–2021 (USD Million)
Table 31 Global Capillary Electrophoresis Market Size, By Country, 2014–2021 (USD Million)
Table 32 Global Surface Plasmon Resonance Market Size, By Country, 2014–2021 USD Million)
Table 33 Global Protein Fractionation Market Size, By Country, 2014–2021 (USD Million)
Table 34 Global Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 35 Global Proteomics Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 36 Global Protein Microarray Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 37 Global Spectroscopy Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 38 Global X-Ray Crystallography Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 39 Global Chromatography Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 40 Global Electrophoresis Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 41 Global Immunoassay Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 42 Global Protein Fractionation Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 43 Global Proteomics Services and Software Market Size, By Type, 2014–2021 (USD Million)
Table 44 Global Proteomics Services and Software Market Size, By Country, 2014–2021 (USD Million)
Table 45 Global Analytical Laboratory Services Market Size, By Type, 2014–2021 (USD Million)
Table 46 Global Analytical Laboratory Services Market Size, By Country, 2014–2021 (USD Million)
Table 47 Global Protein Identification Services Market Size, By Country, 2014–2021 (USD Million)
Table 48 Global Protein Separation Services Market Size, By Country, 2014–2021 (USD Million)
Table 49 Global Protein Sequencing Services Market Size, By Country, 2014–2021 (USD Million)
Table 50 Global Data Analysis and Maintenance Services Market Size, By Type, 2014–2021 (USD Million)
Table 51 Global Data Analysis and Maintenance Services Market Size, By Country, 2014–2021 (USD Million)
Table 52 Global Bioinformatics Databases Market Size, By Country, 2014–2021 (USD Million)
Table 53 Global Bioinformatics Tools Market Size, By Country, 2014–2021 (USD Million)
Table 54 Global Quantitation Services Market Size, By Country, 2014–2021 (USD Million)
Table 55 Global Proteomics Market Size, By Application, 2014–2021 (USD Million)
Table 56 Global Market Size for Drug Discovery, By Country, 2014–2021 (USD Million)
Table 57 Global Proteomics Market Size for Clinical Diagnostics, By Country, 2014–2021 (USD Million)
Table 58 Global Other Proteomics Applications Market Size, By Country, 2014–2021 (USD Million)
Table 59 Global Market for Proteomics Size, By Region, 2014–2021 (USD Million)
Table 60 North America: Proteomics Market Size, By Country, 2014–2021 (USD Million)
Table 61 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 62 North America: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 63 North America: Market for Proteomics: Size, By Reagent, 2014–2021 (USD Million)
Table 64 North America: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 65 U.S.: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 66 U.S.: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 67 U.S.: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 68 U.S.: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 69 Canada: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 70 Canada: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 71 Canada: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 72 Canada: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 73 Europe: Proteomics Market Size, By Country, 2014–2021 (USD Million)
Table 74 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 75 Europe: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 76 Europe: Proteomics Market for Proteomics Size, By Reagent, 2014–2021 (USD Million)
Table 77 Europe: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 78 Germany: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 79 Germany: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 80 Germany: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 81 Germany: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 82 France: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 83 France: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 84 France: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 85 France: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 86 Italy: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 87 Italy: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 88 Italy: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 89 Italy: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 90 U.K.: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 91 U.K.: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 92 U.K.: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 93 U.K.: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 94 Spain: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 95 Spain: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 96 Spain: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 97 Spain: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 98 RoE: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 99 RoE: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 100 RoE: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 101 RoE: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 102 Asia-Pacific: Proteomics Market Size, By Country, 2014–2021 (USD Million)
Table 103 Asia-Pacific: Market Size, By Product, 2014–2021 (USD Million)
Table 104 Asia-Pacific: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 105 Asia-Pacific: Market Size, By Reagent, 2014–2021 (USD Million)
Table 106 Asia-Pacific: Proteomics Market Size, By Service and Software, 2014–2021 (USD Million)
Table 107 China: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 108 China: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 109 China: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 110 China: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 111 India: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 112 India: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 113 India: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 114 India: Proteomics Market Size, By Service and Software, 2014–2021 (USD Million)
Table 115 Japan: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 116 Japan: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 117 Japan: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 118 Japan: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 119 RoAPAC: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 120 RoAPAC: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 121 RoAPAC: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 122 RoAPAC: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 123 Latin America: Proteomics Market Size, By Country, 2014–2021 (USD Million)
Table 124 Latin America: Market Size, By Product, 2014–2021 (USD Million)
Table 125 Latin America: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 126 Latin America: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 127 Latin America: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 128 Brazil: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 129 Brazil: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 130 Brazil: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 131 Brazil: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 132 Mexico: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 133 Mexico: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 134 Mexico: Market Size, By Reagent, 2014–2021 (USD Million)
Table 135 Mexico: Proteomics Market Size, By Service and Software, 2014–2021 (USD Million)
Table 136 RoLA: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 137 RoLA: Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 138 RoLA: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 139 RoLA: Market Size, By Service and Software, 2014–2021 (USD Million)
Table 140 Middle East & Africa: Proteomics Market Size, By Product, 2014–2021 (USD Million)
Table 141 Middle East & Africa: Proteomics Market Size, By Instrumentation Technology, 2014–2021 (USD Million)
Table 142 Middle East & Africa: Proteomics Market Size, By Reagent, 2014–2021 (USD Million)
Table 143 Middle East & Africa: Proteomics Market Size, By Service and Software, 2014–2021 (USD Million)
Table 144 Growth Strategy Matrix (January 2013–November 2016)
Table 145 Global Proteomics Instrumentation Technology Market Ranking Analysis, By Key Players (2015)
Table 146 Global Proteomics Reagent Market Ranking Analysis, By Key Players (2015)
Table 147 Global Proteomics Software Soultion & Services Market Ranking Analysis, By Key Players (2015)
Table 148 Product Launches and Enhancements, 2013–2016
Table 149 Partnerships, Agreements, Alliances, and Collaborations, 2013–2016
Table 150 Acquisitions, 2013–2016
Table 151 Expansions, 2013–2016


List of Figures (40 Figures)

Figure 1 Global Proteomics Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Proteomics Market Size, By Product, 2016 vs 2021 (USD Billion)
Figure 7 Global Proteomics Market Size, By Instrumentation Technology, 2016 vs 2021 (USD Billion)
Figure 8 Global Proteomics Market Size, By Reagent, 2016 vs 2021 (USD Billion)
Figure 9 Global Proteomics Market Size, By Service and Software, 2016 vs 2021 (USD Billion)
Figure 10 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 11 Increasing Demand for Personalized Medicine and Availability of Government and Private Funding to Drive Market Growth
Figure 12 Clinical Diagnosis Accounted for A Major Share of the Asia-Pacific Applications Market
Figure 13 U.S. Commanded the Largest Share of the Proteomics Market in 2015
Figure 14 Asia Pacific to Register High Growth Rates During the Forecast Period
Figure 15 Developing Markets to Register Highest Growth During the Forecast Period
Figure 16 Proteomics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 R&D Expenditure of Top Biotechnology and Pharmaceutical Companies, By Geography, 2012–2014
Figure 18 NIH Funding Levels (2010–2014)
Figure 19 Spectroscopy to Dominate the Market in 2016
Figure 20 Protein Fractionation Kits to Register the Highest Growth Rate During the Forecast Period
Figure 21 Analytical Laboratories to Dominate the Proteomics Services and Software Market From 2016 to 2021
Figure 22 Clinical Diagnostics Segment to Dominate the Proteomics Applications Market From 2016 to 2021
Figure 23 Global Proteomics Market :Geographical Snapshot
Figure 24 North America: Proteomics Market Snapshot
Figure 25 Europe: Proteomics Market Snapshot
Figure 26 Asia-Pacific: Proteomics Market Snapshot
Figure 27 Product Launches and Enhancements—Key Growth Strategy Adopted By Market Players From 2013 to 2016
Figure 28 Strategic Benchmarking: Product Launches and Enhancements (January 2016–November 2016)
Figure 29 Battle for Market Share: Product Launches & Enhancements Command the Largest Share of All Strategies Adopted By Key Players
Figure 30 Geographic Revenue Mix of the Prominent Players in the Proteomics Market
Figure 31 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 32 Company Snapshot: Agilent Technologies, Inc.
Figure 33 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 34 Company Snapshot: Merck KGaA
Figure 35 Company Snapshot: Danaher Corporation
Figure 36 Company Snapshot: Luminex Corporation
Figure 37 Company Snapshot: Perkinelmer, Inc.
Figure 38 Company Snapshot: Waters Corporation
Figure 39 Company Snapshot: GE Healthcare
Figure 40 Company Snapshot: Bruker Corporation

The global proteomics market is estimated to reach USD 21.87 Billion by 2021, at a CAGR of 11.7% during the forecast period. The global market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects. However, a few pivotal factors hampering the growth of this market include the reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers.

In this report, the global proteomics market is majorly segmented on the basis of instrumentation technology, application, reagent, services & software, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global market and its submarkets. On the basis of regent, the protein fractionation reagents segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits of protein fractionation such as high resolution, and effectively separate thousands of proteins in a complex structure. On the basis of services and software, the analytical laboratory services segment commanded for the largest share of the market as these services help in effective diagnosis and research for drug discovery.

On the basis of application, the proteomics market is segmented into drug discovery, clinical diagnostics, and other applications. The clinical diagnostics segment accounted for the largest share of the global market in 2015. This is attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases and drug development.

In this report, the global market have been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. The Asia-Pacific region is expected to register the highest CAGR during the forecast period. The growth of this regional segment is driven by the significant economic development in emerging markets, proteomics technologies playing an integral role in the modern pharmaceutical and healthcare industries, and rising focus of key market players on this region.

Proteomics Market

The major players in the global proteomics market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement


-
Request for FREE Sample of this report Send Request